Multiple Myeloma Rounds
“Innovative and Developing Therapeutic Approaches in the Management of Multiple Myeloma:
Application to Current Practice”
Held in conjunction with Rush University Medical Center Office of Interprofessional Continuing Education (IPCE), and PleXus Communications (PleXus), the Leukemia Research Foundation (LRF) is proud to provide this continuing medical education initiative for the Chicago area and looks forward to expanding it to other major medical communities throughout the United States in 2017.
The Multiple Myeloma Rounds is designed to enhance networking and collaboration among experts in multiple myeloma as well as community oncologists, and to enhance awareness and understanding of investigational therapeutic agents and concepts in multiple myeloma, which are being addressed in clinical trials. The overarching desired outcome is to identify patients who could benefit from these clinical trials.
Multiple Myeloma Rounds is a live meeting series conducted in partnership with seven oncology/hematology departments in medical centers in the Chicago area that have agreed to participate in this important scientific/education exchange. Additionally, in response to increasing global trends in clinician preference and utilization of online education, a series of interactive online enduring activities extends the reach of the educational material presented during the Multiple Myeloma Rounds. Each Multiple Myeloma Rounds will be digitally captured and streamed on-demand, available for credit.
These live and online educational activities are designed to meet the educational needs of hematologists, medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians’ assistants, etc.) involved and/or interested in the therapeutic management of patients with multiple myeloma.
Hematologic Malignancies Summit
Evolving Strategies in the Management of Lymphoma and Myeloma
The overarching goals of this initiative are to incrfease awareness of diagnosis and treatment of hematologic malignancies through outreach to interdisciplinary healthcare professionals. This is a FREE, CME/CE accredited program for healthcare professionals.
Leukemia strikes males and females of all ages and all races. It does not discriminate.
The five-year relative survival rate for non-Hodgkin’s lymphoma and leukemia is about 7% lower for African-Americans than that of whites.
Leukemia is the most common cancer in Hispanic children and adolescents; five-year relative survival rate is 3-4% lower for Hispanics than that of non-Hispanic whites.